VMD Stock Overview
Provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Viemed Healthcare, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$7.41 |
| 52 Week High | US$10.44 |
| 52 Week Low | US$5.90 |
| Beta | 1.38 |
| 1 Month Change | -9.41% |
| 3 Month Change | -18.84% |
| 1 Year Change | -24.46% |
| 3 Year Change | -1.20% |
| 5 Year Change | -4.13% |
| Change since IPO | 313.14% |
Recent News & Updates
Recent updates
When Should You Buy Viemed Healthcare, Inc. (NASDAQ:VMD)?
Apr 11
These 4 Measures Indicate That Viemed Healthcare (NASDAQ:VMD) Is Using Debt Safely
Mar 07Viemed Healthcare: Comments On Q2 Earnings
Aug 25Viemed Healthcare Q2 2022 Earnings Preview
Aug 02Viemed Healthcare: New Bullish Trend Has Just Begun
Dec 29Viemed Healthcare, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 06Viemed Healthcare EPS misses by $0.01, revenue in-line
May 03Strong Execution By Insider-Owners Ensures Viemed's Growth
Jan 11Viemed Healthcare EPS misses by $0.02, beats on revenue
Nov 05Shareholder Returns
| VMD | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 5.0% | 0.3% | -0.6% |
| 1Y | -24.5% | 1.3% | 22.5% |
Return vs Industry: VMD underperformed the US Healthcare industry which returned 1.3% over the past year.
Return vs Market: VMD underperformed the US Market which returned 22.5% over the past year.
Price Volatility
| VMD volatility | |
|---|---|
| VMD Average Weekly Movement | 6.1% |
| Healthcare Industry Average Movement | 6.5% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: VMD's share price has been volatile over the past 3 months.
Volatility Over Time: VMD's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 1,030 | Casey Hoyt | www.viemed.com |
Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices.
Viemed Healthcare, Inc. Fundamentals Summary
| VMD fundamental statistics | |
|---|---|
| Market cap | US$287.66m |
| Earnings (TTM) | US$10.33m |
| Revenue (TTM) | US$194.05m |
27.8x
P/E Ratio1.5x
P/S RatioIs VMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VMD income statement (TTM) | |
|---|---|
| Revenue | US$194.05m |
| Cost of Revenue | US$75.46m |
| Gross Profit | US$118.58m |
| Other Expenses | US$108.25m |
| Earnings | US$10.33m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.27 |
| Gross Margin | 61.11% |
| Net Profit Margin | 5.32% |
| Debt/Equity Ratio | 5.6% |
How did VMD perform over the long term?
See historical performance and comparison